title: Glucose effects on lung surfactant kinetics in conscious pigs.
abstract: The primary goal of this study was to investigate the effects of glucose infusion on surfactant phosphatidylcholine (PC) metabolic kinetics in the lungs. A new stable isotope tracer model was used in which [1,2-(13)C(2)]acetate and uniformly labeled [U-(13)C(16)]palmitate were infused in 12 normal overnight-fasted pigs to quantify lung surfactant kinetics with or without glucose infusion (24 mg. kg(-1). min(-1)). With glucose infusion, the rate of surfactant PC incorporation from de novo synthesized palmitate increased from the control value of 2.1 +/- 0.2 to 15.5 +/- 1.9 nmol PC-bound palmitate. h(-1). g wet lung(-1) (P < 0.05), whereas the incorporation rate from plasma preformed palmitate decreased from the control value of 20.9 +/- 1.9 to 11.6 +/- 1.1 nmol palmitate. h(-1). g wet lung(-1) (P < 0.05). The palmitate composition in lamellar body surfactant PC increased from the control value of 61.7 +/- 2.1% to 75.9 +/- 0.6% (P < 0.05). The surfactant PC secretion rate decreased from the control value of 239.0 +/- 26.1 to 81.9 +/- 5.3 nmol PC-bound palmitate. h(-1). g wet lung(-1) (P < 0.05). We conclude that, whereas surfactant secretion was inhibited by glucose infusion, neither total surfactant PC synthesis nor the surfactant PC pool size was significantly affected due to an increased reliance on de novo synthesized fatty acids.
authors.affiliation: Shriners Burns Hospital and the Departments of Surgery and Anesthesiology, The University of Texas Medical Branch, Galveston, Texas 77555, USA.
authors.forename: W Z
authors.initials: WZ
authors.lastname: Martini
authors.forename: O
authors.initials: O
authors.lastname: Irtun
authors.forename: D L
authors.initials: DL
authors.lastname: Chinkes
authors.forename: R E
authors.initials: RE
authors.lastname: Barrow
authors.forename: R R
authors.initials: RR
authors.lastname: Wolfe
mesh_terms: D000818:Animals; D001786:Blood Glucose; D002247:Carbon Isotopes; D005230:Fatty Acids, Nonesterified / Q000032:analysis / Q000096:biosynthesis / Q000097:blood; D005947:Glucose / Q000008:administration & dosage / Q000378:metabolism*; D006943:Hyperglycemia / Q000097:blood / Q000139:chemically induced; D006946:Hyperinsulinism / Q000097:blood / Q000139:chemically induced; D007262:Infusions, Intravenous; D007328:Insulin / Q000097:blood; D008079:Lipoproteins, VLDL / Q000097:blood; D008099:Liver / Q000378:metabolism; D008168:Lung / Q000187:drug effects / Q000378:metabolism*; D009928:Organ Specificity; D010168:Palmitates / Q000378:metabolism; D011663:Pulmonary Surfactants / Q000737:chemistry / Q000378:metabolism*; D013552:Swine; D014280:Triglycerides / Q000097:blood
chemical_list: D001786:Blood Glucose; D002247:Carbon Isotopes; D005230:Fatty Acids, Nonesterified; D007328:Insulin; D008079:Lipoproteins, VLDL; D010168:Palmitates; D011663:Pulmonary Surfactants; D014280:Triglycerides; C030106:very low density lipoprotein triglyceride; D005947:Glucose